An open labeled clinical trial to evaluate efficacy and safety of Diacare in patients with type 2 diabetes mellitus

Admark Herbals Limited0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Aged 30 to 65 years
•Male and female patients with Type 2 diabetes
•Patients with inadequate glucose control on any anti diabetic drugs
•Body mass index between 20-35 kg/m2
•Having fasting blood glucose > 126 mg/dL
•Post prandial blood glucose > 200 mg/dL
•Having no serious physical or biochemical abnormalities other than those generally associated with type 2 diabetes and who are willing to give written informed consent

•Patients having diabetes other than non insulin dependent diabetes mellitus
•Having history of hypersensitivity, liver or kidney damage or gastrointestinal disorders, acute infections, diseases of blood or hematopoietic organs
•Pregnant or lactating women and patients receiving any concomitant medication, which may have interacted with hypoglycemic action of study drug
•Previous participation in a clinical trial in the last 6 months.

发起方

Admark Herbals Limited